Biogen Looks To Bulk Up Rare Disease Portfolio With $7.3 Billion Acquisition

Biogen will pay $172.50 per share in cash for Reata, which had a Thursday closing price of $108.

55), andThe company was founded in Plano, Texas in 2002 and focuses on antioxidative and anti-inflammatory drugsBiogen, a Massachusetts-based biotech company with a market cap of nearly $38 billion, has acquired three other companies in the last eight years. The $200 million

ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว